New York State Common Retirement Fund’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$445K Buy
24,750
+5,600
+29% +$78.3K ﹤0.01% 2056
2026
Q1
$180K Hold
19,150
﹤0.01% 2274
2025
Q4
$238K Hold
19,150
﹤0.01% 2216
2025
Q3
$274K Hold
19,150
﹤0.01% 2156
2025
Q2
$235K Sell
19,150
-4,000
-17% -$58.1K ﹤0.01% 2191
2025
Q1
$509K Sell
23,150
-300
-1% -$7.05K ﹤0.01% 1878
2024
Q4
$532K Hold
23,450
﹤0.01% 1921
2024
Q3
$426K Sell
23,450
-50,726
-68% -$1.18M ﹤0.01% 1993
2024
Q2
$2.16M Sell
74,176
-3,149
-4% -$93.4K ﹤0.01% 1450
2024
Q1
$2.74M Sell
77,325
-9,252
-11% -$370K ﹤0.01% 1342
2023
Q4
$3.77M Sell
86,577
-3,956
-4% -$156K 0.01% 1219
2023
Q3
$3.46M Sell
90,533
-3,458
-4% -$145K 0.01% 1243
2023
Q2
$3.87M Buy
93,991
+2,140
+2% +$103K ﹤0.01% 1269
2023
Q1
$5.27M Buy
91,851
+16,032
+21% +$903K 0.01% 1143
2022
Q4
$4.25M Sell
75,819
-20
-0% -$1.02K 0.01% 1251
2022
Q3
$3.21M Sell
75,839
-2,659
-3% -$136K ﹤0.01% 1373
2022
Q2
$4.24M Sell
78,498
-1,778
-2% -$107K 0.01% 1277
2022
Q1
$5.16M Sell
80,276
-416
-0.5% -$27.4K 0.01% 1271
2021
Q4
$5.41M Sell
80,692
-3,185
-4% -$215K 0.01% 1264
2021
Q3
$5.74M Buy
83,877
+3,777
+5% +$267K 0.01% 1252
2021
Q2
$5.47M Sell
80,100
-3,000
-4% -$212K 0.01% 1304
2021
Q1
$5.74M Sell
83,100
-11,500
-12% -$779K 0.01% 1213
2020
Q4
$6.14M Sell
94,600
-34,400
-27% -$1.85M 0.01% 1175
2020
Q3
$6.09M Sell
129,000
-9,700
-7% -$461K 0.01% 1084
2020
Q2
$6.52M Sell
138,700
-11,300
-8% -$555K 0.01% 1052
2020
Q1
$6.7M Buy
150,000
+750
+0.5% +$39.4K 0.01% 944
2019
Q4
$8.7M Buy
149,250
+14,550
+11% +$866K 0.01% 1014
2019
Q3
$8.09M Sell
134,700
-1,000
-0.7% -$59.6K 0.01% 1031
2019
Q2
$7.58M Sell
135,700
-1,600
-1% -$82.4K 0.01% 1101
2019
Q1
$7.65M Sell
137,300
-3,300
-2% -$168K 0.01% 1070
2018
Q4
$6.34M Sell
140,600
-4,000
-3% -$219K 0.01% 1080
2018
Q3
$9.53M Buy
144,600
+2,300
+2% +$143K 0.01% 1035
2018
Q2
$9.17M Buy
142,300
+72,200
+103% +$4.47M 0.01% 1049
2018
Q1
$3.88M Sell
70,100
-2,861
-4% -$150K ﹤0.01% 1314
2017
Q4
$3.49M Sell
72,961
-42,351
-37% -$2.07M ﹤0.01% 1372
2017
Q3
$5.82M Sell
115,312
-16,954
-13% -$871K 0.01% 1157
2017
Q2
$7.21M Buy
132,266
+1,899
+1% +$90.7K 0.01% 1099
2017
Q1
$5.49M Buy
130,367
+1
+0% +$43 0.01% 1201
2016
Q4
$5.59M Buy
130,366
+4,000
+3% +$163K 0.01% 1199
2016
Q3
$5.22M Buy
126,366
+4,000
+3% +$168K 0.01% 1210
2016
Q2
$4.88M Buy
122,366
+17,628
+17% +$634K 0.01% 1238
2016
Q1
$3.53M Buy
104,738
+51,938
+98% +$1.62M 0.01% 1360
2015
Q4
$1.79M Buy
52,800
+2,000
+4% +$62.5K ﹤0.01% 1655
2015
Q3
$1.51M Sell
50,800
-79,064
-61% -$2.47M ﹤0.01% 1731
2015
Q2
$3.58M Buy
129,864
+11,773
+10% +$314K 0.01% 1534
2015
Q1
$2.98M Hold
118,091
﹤0.01% 1474
2014
Q4
$2.62M Buy
118,091
+6,116
+5% +$124K ﹤0.01% 1510
2014
Q3
$2.27M Sell
111,975
-18,349
-14% -$365K ﹤0.01% 1567
2014
Q2
$2.51M Buy
130,324
+4,893
+4% +$91.2K ﹤0.01% 1575
2014
Q1
$2.36M Buy
125,431
+7,584
+6% +$146K ﹤0.01% 1587
2013
Q4
$2.3M Buy
117,847
+1,713
+1% +$31.4K ﹤0.01% 1580
2013
Q3
$1.91M Hold
116,134
﹤0.01% 1580
2013
Q2
$1.74M Buy
+116,134
New +$1.7M ﹤0.01% 1497

Other funds holding IART

New York State Common Retirement Fund's IART Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Integra LifeSciences (IART) stake by 29% in Q2 2026, buying an estimated $78.3K and bringing the position to 24,750 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

New York State Common Retirement Fund first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.53M in Q3 2018. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • New York State Common Retirement Fund held 24,750 shares of Integra LifeSciences worth $445K as of Q2 2026.
  • New York State Common Retirement Fund bought 5,600 Integra LifeSciences shares in Q2 2026, an estimated $78.3K.
  • Integra LifeSciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2056 holding.
  • New York State Common Retirement Fund first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
  • New York State Common Retirement Fund's Integra LifeSciences position peaked at $9.53M in Q3 2018.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.